Positron Emission Tomography (PET) Imaging With Zirconium-89 (89Zr)-Trastuzumab for Prediction of HER2 Targeted Therapy Effectiveness
Clinical trial NCT03321045 · RECRUITING
Trial details
- NCT number
- NCT03321045
- Sponsor
- University of Alabama at Birmingham
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-21
- Primary completion
- 2028-10-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.